DHMEQ, known to inhibit the activation of NF-κB by preventing the nuclear translocation of its active subunit p65 (Ohsugi et al., 2006), showed a significantly prolonged survival and prevented tumor growth in an ATL NSG xenograft mouse model (Ohsugi et al., 2007a). This evidence concerns the gene NFKB1 and neoplasm.